Is Eli Lilly Stock A Buy After Weight-Loss Drug Prevents Diabetes?
In this article:
Is Eli Lilly stock a buy after the company said its weight-loss drug reduced the risk of developing diabetes by 94%?
Advertisement
Some parts of this page are not supported on your current browser version. Please upgrade to a recent browser version.
Is Eli Lilly stock a buy after the company said its weight-loss drug reduced the risk of developing diabetes by 94%?